Carcinoembryonic antigen (CEA), a broadly studied tumor marker, is an attractive clinical cancer indicator in colon tumors, breast tumors, ovarian carcinomas, colorectal cancer and cystadenocarcinomas [3]. This evidence concerns the gene CEACAM5 and cystadenocarcinoma.